Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China · Delayed Price · Currency is CNY 46.94
-0.37 (-0.78%)
Jun 10, 2026, 4:00 PM EDT
SHE:301033 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 109.68 | 113.13 | 78.85 | 40.88 | 35.73 | 44.71 |
Depreciation & Amortization | 27.08 | 27.08 | 27.13 | 25.33 | 15.16 | 8.19 |
Other Amortization | 0.99 | 0.99 | 0.79 | 1.22 | 1.35 | 1.46 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0 | - | -0.17 | -0.01 |
Asset Writedown & Restructuring Costs | 2.7 | 2.7 | 0.48 | 0.22 | 1.25 | 0.01 |
Loss (Gain) From Sale of Investments | -3.17 | -3.17 | -3.59 | -3.69 | -7.99 | -7.08 |
Provision & Write-off of Bad Debts | -0.05 | -0.05 | 0.1 | 0.04 | 0.03 | -0.05 |
Other Operating Activities | -20.31 | 2.25 | -1.15 | 2.21 | -1.93 | 1.1 |
Change in Accounts Receivable | -3.93 | -3.93 | -4.43 | -7.14 | -6.78 | 2.2 |
Change in Inventory | -5.29 | -5.29 | -8.15 | 3.19 | -8.27 | -4.64 |
Change in Accounts Payable | -3.41 | -3.41 | 16.18 | 43.8 | 16.18 | 17.92 |
Change in Other Net Operating Assets | 9.49 | 9.49 | 13.18 | 5.44 | -0.2 | - |
Operating Cash Flow | 113.86 | 139.87 | 116.38 | 107.69 | 48.31 | 66.51 |
Operating Cash Flow Growth | -12.21% | 20.18% | 8.08% | 122.91% | -27.37% | 96.15% |
Capital Expenditures | -27.23 | -23.82 | -33.16 | -40.09 | -135.96 | -152.71 |
Sale of Property, Plant & Equipment | 0.08 | 0.08 | 0.03 | 0.03 | 0.06 | 0.01 |
Investment in Securities | 18.92 | -81.42 | 28.81 | -41.84 | 157.9 | -162.23 |
Other Investing Activities | -40.4 | -40.46 | -4.01 | - | -3.45 | - |
Investing Cash Flow | -48.63 | -145.62 | -8.33 | -81.9 | 18.55 | -314.93 |
Long-Term Debt Issued | - | - | - | - | - | 54.12 |
Long-Term Debt Repaid | - | -1.12 | -52.34 | -28.62 | -27.18 | -2.77 |
Net Debt Issued (Repaid) | -1.12 | -1.12 | -52.34 | -28.62 | -27.18 | 51.34 |
Issuance of Common Stock | 12.63 | 12.63 | 9.31 | - | - | 250.05 |
Repurchase of Common Stock | - | - | -11.51 | - | - | - |
Common Dividends Paid | -39.7 | -39.7 | -27.14 | -15.28 | -8.05 | - |
Other Financing Activities | 0.51 | - | - | - | - | -53.9 |
Financing Cash Flow | -27.68 | -28.2 | -81.67 | -43.9 | -35.23 | 247.49 |
Foreign Exchange Rate Adjustments | -0.21 | 0.32 | 0.16 | 0.02 | 2.97 | -0.42 |
Net Cash Flow | 37.35 | -33.62 | 26.54 | -18.09 | 34.61 | -1.35 |
Free Cash Flow | 86.63 | 116.05 | 83.22 | 67.6 | -87.65 | -86.2 |
Free Cash Flow Growth | -15.39% | 39.44% | 23.11% | - | - | - |
Free Cash Flow Margin | 23.20% | 31.46% | 29.89% | 29.28% | -44.89% | -56.05% |
Free Cash Flow Per Share | 1.30 | 1.73 | 1.27 | 1.02 | -1.32 | -1.52 |
Cash Income Tax Paid | 49.96 | 48.62 | 38.7 | 19.36 | 6.68 | 4.13 |
Levered Free Cash Flow | 68.8 | 85.06 | 15.16 | 17.89 | -118 | -127.14 |
Unlevered Free Cash Flow | 68.81 | 85.07 | 15.72 | 19.27 | -116.88 | -126.83 |
Change in Working Capital | -3.05 | -3.05 | 13.78 | 41.48 | 4.87 | 18.17 |